Navigation Links
Cadence Pharmaceuticals Completes $49.3 Million Registered Direct Offering
Date:2/20/2008

SAN DIEGO, Feb. 20 /PRNewswire-FirstCall/ -- Cadence Pharmaceuticals, Inc. (Nasdaq: CADX), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting, today announced that it completed its previously announced registered direct offering of approximately 9.2 million shares of common stock at a price of $5.34 per share, for gross proceeds of $49.3 million.

"The proceeds from the offering will enable us to continue to advance the clinical development programs for our two products candidates, Acetavance(TM) for the treatment of acute pain and fever, and Omigard(TM) for the prevention of catheter-related infections," stated Ted Schroeder, President and Chief Executive Officer of Cadence. "We believe that we now have sufficient capital to advance these two product candidates through to NDA submissions, currently anticipated in the first half of 2009."

In addition to significant participation from existing investors Domain Associates, Frazier Healthcare Ventures and Versant Ventures, as well as from certain executive officers and directors of Cadence, other investors participating in this financing included, among others, Bay City Capital.

All of the shares of Cadence common stock were issued pursuant to an effective registration statement previously filed with the U.S. Securities and Exchange Commission. The offering and sale of these securities were made only by means of a prospectus supplement and accompanying prospectus. This press release shall not constitute an offer to sell, or a solicitation of an offer to buy, nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale
'/>"/>

SOURCE Cadence Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Cadence Pharmaceuticals to Raise up to $49.3 Million in Registered Direct Common Stock Offering
2. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference on February 5, 2008 in New York
3. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Third Quarter 2007 Financial Results
4. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at BIOCOM Investor Conference 2007
5. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at BIO Investor Forum
6. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at UBS 2007 Global Life Sciences Conference
7. Cadence Pharmaceuticals Names Malvina Laudicina Vice President of Regulatory Affairs and Quality Assurance
8. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
9. Addrenex Pharmaceuticals Reaches Milestone with Filing of NDA for First Product, CloniBID, to Treat Hypertension
10. Vion Pharmaceuticals to Implement a One-for-Ten Reverse Stock Split
11. Sunesis Pharmaceuticals Announces Milestone Payment from Inflammation Collaboration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... Research and Markets has announced the addition ... In-situ hybridization, Immunohistochemistry) Market - Trends & Forecasts to ... The global companion diagnostics market is expected to grow ... Factors such as rising need for personalized medicine in ... pharmaceutical industry, support from regulatory authorities, and emerging technologies ...
(Date:9/18/2014)... , Sept. 18, 2014  U.S. biotech company ... an exclusive license for technology developed by the ... expression in plants, including for applications in production of ... The technology was developed under the direction of ... Kultevat and former president of the Danforth Plant Science ...
(Date:9/18/2014)... Sept. 18, 2014  Neogen Corporation (Nasdaq: ... a strategic agreement with Merck Animal Health to market ... The Igenity Dairy Heifer Program consists of genomic ... the genetic potential of replacement dairy heifers. The genomic ... born, and is an excellent tool in the decision-making ...
(Date:9/18/2014)... , Pennsylvanie, 18 septembre 2014 ... en 1974, a été depuis 40 ... les évaluations cliniques traditionnelles par des évaluations ... et sur les impacts économiques des traitements. ... A cours d,une récente ...
Breaking Biology Technology:Global Companion Diagnostics (Polymerase Chain Reaction, In-situ hybridization, Immunohistochemistry) Market - Trends & Forecasts to 2019 2Global Companion Diagnostics (Polymerase Chain Reaction, In-situ hybridization, Immunohistochemistry) Market - Trends & Forecasts to 2019 3Kultevat obtains license of gene switch technology 2Merck Animal Health to market Neogen's dairy genomic program 21974 - 2014 - Mapi fĂȘte ses 40 ans 2
... -- BMP,Sunstone Corporation (Nasdaq: BJGP ) ("BMP Sunstone" or ... year ended,December 31, 2008. , , Financial Highlights ... revenues increased to $36.6 million, from $9.2 million, ... -- Non-GAAP operating income, as defined below, was $3.5 million ...
... Mich., March 17 MichBio, the association for Michigan ... of San Diego, CA-based Sequenom, Inc. as the keynote ... the Kensington Court Hotel in Ann Arbor. Sequenom ... of the Center for Molecular Medicine (CMM) in Grand ...
... Upcoming SharpBrains Market Report at IHRSA 2009 Convention. , ... ... of SharpBrains and member of the World Economic Forum,s Council on ... (International Health, Racquet and Sportsclub Association) Annual Convention the results of ...
Cached Biology Technology:BMP Sunstone Reports Fourth Quarter and Full Year 2008 Financial Results 2BMP Sunstone Reports Fourth Quarter and Full Year 2008 Financial Results 3BMP Sunstone Reports Fourth Quarter and Full Year 2008 Financial Results 4BMP Sunstone Reports Fourth Quarter and Full Year 2008 Financial Results 5BMP Sunstone Reports Fourth Quarter and Full Year 2008 Financial Results 6BMP Sunstone Reports Fourth Quarter and Full Year 2008 Financial Results 7BMP Sunstone Reports Fourth Quarter and Full Year 2008 Financial Results 8BMP Sunstone Reports Fourth Quarter and Full Year 2008 Financial Results 9BMP Sunstone Reports Fourth Quarter and Full Year 2008 Financial Results 10BMP Sunstone Reports Fourth Quarter and Full Year 2008 Financial Results 11BMP Sunstone Reports Fourth Quarter and Full Year 2008 Financial Results 12MichBio Announces Annual Business Meeting Keynote and Pre-Meeting Workshop 2MichBio Announces Annual Business Meeting Keynote and Pre-Meeting Workshop 3New Brain Fitness Survey Reinforces Importance of Brain Awareness Week 2New Brain Fitness Survey Reinforces Importance of Brain Awareness Week 3New Brain Fitness Survey Reinforces Importance of Brain Awareness Week 4
(Date:9/18/2014)... manipulate spoken language is unique to humans. "The genetic ... of human evolution to make this possible are largely ... now have," says Wolfgang Enard, Professor of Anthropology and ... the molecular biological basis of language Enard has now ... latest study, undertaken in collaboration with scientists at several ...
(Date:9/18/2014)... Arizona turned its newborn screening program into a model other ... it the first-ever Newborn Screening Quality Award from the March ... Humble, M.P.H., Arizona,s Department of Health Services director, with the ... a policy of full transparency for the length of time ... the lab for analysis, and set a target of having ...
(Date:9/18/2014)... be celebrated tonight at the third annual Golden Goose ... of premature infants and in paving the way for ... was supported by the National Science Foundation, the National ... will be honored at a ceremony at the Library ... Members of Congress will be on hand to help ...
Breaking Biology News(10 mins):Language evolution: Quicker on the uptake 2Language evolution: Quicker on the uptake 3March of Dimes honors Arizona with first-ever newborn screening award 2March of Dimes honors Arizona with first-ever newborn screening award 33rd annual Golden Goose award ceremony honors 8 researchers; Unusual work had big results 2
... the making is telling the story of humans, impact on ... to Ontario are shaping the future of an ecosystem that ... an article to be published online Dec. 17 in the ... group led by researchers at the University of Michigan reports ...
... Maryland School of Medicine researchers have launched groundbreaking research ... the developing Southeast Asian nation of Myanmar, also known ... large international team coordinated by the World Health Organization ... be used to develop tests to identify and track ...
... transpacific dust plumes deliver vast quantities of microbes to ... of print in the journal Applied and Environmental ... microbial species, many of which seem particularly well-suited for ... graduate student at the University of Washington, Seattle. "We ...
Cached Biology News:Environmental threat map highlights Great Lakes restoration challenges 2Environmental threat map highlights Great Lakes restoration challenges 3Environmental threat map highlights Great Lakes restoration challenges 4Univ. of MD School of Medicine to study drug-resistant malaria in Myanmar 2Univ. of MD School of Medicine to study drug-resistant malaria in Myanmar 3Univ. of MD School of Medicine to study drug-resistant malaria in Myanmar 4Univ. of MD School of Medicine to study drug-resistant malaria in Myanmar 5Dust-plumes power intercontinental microbial migrations 2